![Image may contain: Person, Clothing, Hair, Plant, Arm.](/farmasi/english/research/groups/pharmatox/news/image002.jpg)
Ingliv Gjetmundsen (FAI) defended her master's thesis entitled “Escitalopram og venlafaksin reduserer viabilitet og GluN2B-uttrykk. Studier i PC12-, SH-SY5Y-celler og kyllingembryo”, June 2021. Her main supervisor was Professor Ragnhild Elisabeth Paulsen, Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, UiO.
Congratulations!